Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) is a publicly traded the market company. As of July 7, 2026, LABT trades at $2.70 with a market cap of $4.81M and a P/E ratio of 0.00. LABT moved +0.00% today. Year to date, LABT is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $2.41 to $98.20. Rallies surfaces LABT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for LABT, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.70 |
| Market Cap | $4.81M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $98.20 |
| 52-Week Low | $2.41 |
| Volume | 44.71K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
LABT analyst coverage data. Average price target: $0.00.